Crossmark

Higher doses of naloxone are needed in the synthetic opioid era

Crossref DOI link: https://doi.org/10.1186/s13011-019-0195-4

Published Online: 2019-02-18

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Moss, Ronald B.

Carlo, Dennis J.
License Information

Text and Data Mining valid from 2019-02-18
More Information

Article History

Received: 19 November 2018

Accepted: 4 February 2019

First Online: 18 February 2019

Ethics approval and consent to participate

: NA

: NA

: All authors are employees of Adamis Pharmaceuticals which supported this work.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.